Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
202 Leser
Artikel bewerten:
(1)

Apica Inc.: Apica Launches Ascent Freemium to Democratize Intelligent Telemetry Data Management and Observability

Finanznachrichten News

STOCKHOLM and LOS ANGELES, Jan. 22, 2025version of its Ascent platform, providing free access to enterprise-grade telemetry pipeline management and intelligent observability. Ascent is designed to help organizations centrally manage and automate their telemetry data workflows, gain key insights from their data, and maximize their users' digital experience.

Blog: Free enterprise-grade telemetry data management and observability is here

Ascent Freemium offers users access to essential telemetry data management and observability features, including:

  • Processing of up to 1TB/month of logs, metrics, traces, events, and alerts
  • Monthly data ingestion, unlimited users, and no storage costs
  • Unlimited users and dashboards for team collaboration
  • Integration with popular platforms, including Kafka, ElasticSearch, Splunk, and Datadog
  • Support for OpenTelemetry, Fluent Bit, Logstash, and other open-source agents
  • Fleet management for data collection supporting up to 25 agents, including OpenTelemetry Collector for Windows, Linux, and Kubernetes
  • 10 URL, Ping, Port, and SSL checks for maximizing the digital experience

"We are continuing our mission of making observability and data management intelligent and more affordable and look forward to supporting more teams in their endeavors to make sense of all their valuable data," said Mathias Thomsen, CEO of Apica. "With Ascent Freemium, we're removing a barrier to entry for any business that wants to unlock the value of their data. This is a significant step toward fulfilling our vision of giving customers an intelligent and simplified way to manage and observe their data through a single pane of glass."

The launch of Ascent Freemium comes when organizations of all sizes are cost-conscious and seek unified platforms that simplify observability and enable holistic insights into system and application performance.

"Apica's launch of Ascent Freemium makes enterprise-grade telemetry management accessible to organizations of all sizes," said Dan Twing, President and COO at Enterprise Management Associates (EMA). "With its seamless support for OpenTelemetry, AI-driven insights, and robust scalability, Ascent Freemium empowers IT teams to achieve full-stack visibility and actionable insights without the financial and operational barriers that often accompany such solutions."

Ascent Freemium users can seamlessly upgrade to paid tiers as their needs evolve, ensuring a smooth transition as organizations scale their data management operations. Apica will continue to offer its other licensing tiers for organizations requiring advanced features, higher processing volumes, on-premises implementations, and dedicated support.

"Today, organizations face spiraling costs associated with complex systems and integrations. With Ascent Freemium, we offer a comprehensive platform that consolidates telemetry data management and observability, while leveraging AI/ML workflows and built-in AI agents to significantly reduce troubleshooting time. The platform builds on users' existing data and use cases, enabling them to accelerate OpenTelemetry adoption while reducing costs and complexity," said Ranjan Parthasarathy, CTO/CPO of Apica.

Availability

Ascent Freemium is available immediately for enterprise customers. Organizations can also sign up for it at https://www.apica.io/freemiumwithout requiring a credit card.

Connect with Apica
X
LinkedIn

About Apica
Apica delivers intelligent telemetry data management and observability through its unified platform, Ascent. Built on AI/ML workflows, AI agents, and powerful root cause analysis tools, Ascent greatly simplifies the complexity of handling telemetry data. The platform provides an integrated solution for data collection, telemetry pipeline management, storage, and comprehensive observability functions. Through a single pane of glass, organizations can efficiently collect, transform, route, store, observe, and analyze their data while maintaining complete cost control. This enables them to quickly identify and resolve performance issues before they impact end users. For more information, visit www.apica.io


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.